Author: Ivan Oransky

Retraction count grows to 35 for scientist who faked emails to do his own peer review

Hyung-In Moon

Hyung-In Moon, the South Korean plant compound researcher who made up email addresses so he could do his own peer review, is now up to 35 retractions.

The four new retractions are of the papers in the Journal of Enzyme Inhibition and Medicinal Chemistry that initially led to suspicions when all the reviews came back within 24 hours. Here’s the notice, which includes the same language as Moon’s 24 other retractions of studies published in Informa Healthcare journals: Continue reading Retraction count grows to 35 for scientist who faked emails to do his own peer review

PLoS ONE GMO cassava paper retracted after data “could not be found”

via Wikimedia

The authors of a paper suggesting that cassava, a starchy vegetable that’s a major food source in much of the developing world, could one day be turned into a food staple “capable of supplying inexpensive, plant-based proteins for food, feed and industrial applications” have retracted it, following an institutional investigation that failed to find critical supporting data.

Here’s the notice for the PLoS ONE study, “Transgenic Biofortification of the Starchy Staple Cassava (Manihot esculenta) Generates a Novel Sink for Protein:” Continue reading PLoS ONE GMO cassava paper retracted after data “could not be found”

Senior author “fully confident” in paper that cites retracted Cell study and shares first author

Last week, we reported on an investigation at Glasgow’s Beatson Institute for Cancer Research into the circumstances of a retraction in Cell. That retraction wasn’t signed by the paper’s first author, Lynne Marshall, who had since moved on to another institution. (We have yet to hear back from Marshall about why she didn’t sign.)

As a commenter on that post pointed out, Marshall was the first author on an EMBO Journal paper that cited the now-retracted Cell paper several times. So we wanted to find out if there were any questions about the EMBO Journal paper, “Nutrient/TOR-dependent regulation of RNA polymerase III controls tissue and organismal growth in Drosophila,” published in February of this year. Savraj Grewal, Marshall’s PI at the University of Calgary until her postdoc ended earlier this summer, tells Retraction Watch: Continue reading Senior author “fully confident” in paper that cites retracted Cell study and shares first author

Hip, hip, hooray! Hip journal retracts paper that had, well, everything wrong with it

Sometimes, you just gotta retract.

Here’s the retraction notice for “Outcome of short proximal femoral nail antirotation and dynamic hip screw for fixation of unstable trochanteric fractures. A randomised prospective comparative trial,” originally published in Hip International in 2011 by a group of researchers at the All India Institute of Medical Sciences in New Delhi: Continue reading Hip, hip, hooray! Hip journal retracts paper that had, well, everything wrong with it

ORI findings lead to two retractions — nearly 17 years later

Well, it only took 17 years.

As two retraction notices in the September 15 issue of the Journal of Immunology note:

On October 19, 1995, the Office of Research Integrity at the National Institutes of Health found that Weishu Y. Weiser, Ph.D., formerly of the Harvard Medical School at Brigham and Women’s Hospital, committed scientific misconduct by falsifying data in biomedical research supported by two Public Health Service grants. As a result, she agreed to submit a letter to The Journal of Immunology to retract this article. The offices of The Journal of Immunology have no record of receiving such a letter and hence the article is now being retracted.

The retractions, for “Recombinant Migration Inhibitory Factor Induces Nitric Oxide Synthase in Murine Macrophages” and “Human Recombinant Migration Inhibitory Factor Activates Human Macrophages to Kill Leishmania donovani,” both say the same thing.

“Recombinant Migration Inhibitory Factor Induces Nitric Oxide Synthase in Murine Macrophages” has been  cited 66 times, according to Thomson Scientific’s Web of Knowledge — 40 of those times since the ORI’s report was released. The numbers for the Leishmania paper are almost identical: Continue reading ORI findings lead to two retractions — nearly 17 years later

Fifth Alirio Melendez retraction offers clues about University of Glasgow misconduct findings

A new retraction — his fifth — in the Journal of Immunology for Alirio Melendez, formerly of the National University of Singapore, the University of Glasgow, and the University of Liverpool, sheds some light on the results of an investigation by one of the universities.

Last month, a Glasgow spokesperson told Nature that the university’s investigation had been completed in October 2011, but that it did not comment on individual cases. A spokesperson, according to the Times Higher Education:

…would say only that there was “no evidence that our current staff contributed, falsified or duplicated data to any publications co-authored with (Professor) Melendez”. He also confirmed that relevant journals would be contacted where retractions or corrections were deemed necessary.

The notice for one such necessary retraction, in the September 15 issue of the Journal of Immunology, gives a few details: Continue reading Fifth Alirio Melendez retraction offers clues about University of Glasgow misconduct findings

Retraction count for Dipak Das rises to 17

We have four more retractions by Dipak Das, the disgraced UConn researcher found by the university to have committed 145 counts of misconduct. All appear in the Journal of Molecular and Cellular Cardiology (we left the journal off when we initially posted, as commenters noted):

“Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling,” cited 28 times, according to Thomson Scientific’s Web of Knowledge:
Continue reading Retraction count for Dipak Das rises to 17

Korean cardiology journal retracts one paper for plagiarism, and another for duplication

A Korean cardiology journal has retracted a 2011 review article because it “seriously” plagiarized a 2009 paper in another journal.

Here’s the notice, which is dated May 24, 2012 but just came to our attention, thanks to a post by Marilyn Mann: Continue reading Korean cardiology journal retracts one paper for plagiarism, and another for duplication

Glasgow’s Beatson Institute investigating circumstances of Cell retraction for inappropriate images

The Beatson Institute for Cancer Research in Glasgow, Scotland is looking into how inappropriate images ended up in a Cell paper that has just been retracted.

Here’s the notice for the paper by Lynne Marshall, Niall S. Kenneth, and Robert J. White: Continue reading Glasgow’s Beatson Institute investigating circumstances of Cell retraction for inappropriate images

Former Harvard psychology prof Marc Hauser committed misconduct in four NIH grants: ORI

Two years after questions surfaced about work by former Harvard psychology professor Marc Hauser, an official government report is finally out.

It’s not pretty.

The findings by the Office of Research Integrity were first reported by the Boston Globe, which was also first to report the issues in Hauser’s work. They’re extensive, covering misconduct in four different NIH grants (we’ve added some links for context): Continue reading Former Harvard psychology prof Marc Hauser committed misconduct in four NIH grants: ORI